Form 4: Insulet Director Robert Huffines Acquires PODD Shares

Director Robert Huffines acquired 111 shares of Insulet Corporation common stock via the company's deferred compensation plan.

Summary

• Director Robert Luther Huffines acquired 111 shares of Insulet Corporation (PODD) common stock.
• The transaction occurred on March 31, 2026.
• The shares were acquired at a price of $209.84 per share.
• These shares were received as deferred common stock units in lieu of cash compensation under the company's Deferred Compensation Plan for Non-Employee Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing reflecting standard director compensation practices with no material impact on company strategy or financial health.

Positives

• Director demonstrates alignment with shareholder interests by accepting equity in lieu of cash compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The deferred common stock units will be converted into shares of common stock on a one-for-one basis upon distribution, which occurs at the election of the director in either a lump sum or annual installments.

Industry Context

StockSavvy.ai notes that director participation in deferred compensation plans via equity is a standard corporate governance practice, signaling long-term commitment to the issuer's performance.

Comparison to Industry Standards

• The use of deferred compensation plans for non-employee directors is consistent with standard practices among S&P 500 and mid-cap healthcare technology companies to preserve cash and align director incentives.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal impact; reflects standard director compensation.

Next Steps

• Future conversion of deferred units into common stock at the director's election.

Key Dates

Keywords

Insulet, PODD, Director, Insider Trading, Form 4, Deferred Compensation